PANCREATIC NEUROENDOCRINE CARCINOMA
Clinical trials for PANCREATIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ESK981 takes on tough cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called ESK981 in people with advanced pancreatic cancer, certain neuroendocrine tumors, or neuroendocrine prostate cancer. Participants take ESK981 capsules in a 5-days-on, 2-days-off cycle. The main goal is to see if the drug can keep the ca…
Matched conditions: PANCREATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Scientists launch massive pancreas disease data & tissue bank
Knowledge-focused Recruiting nowThis study collects medical information, blood, tissue, and other samples from up to 20,000 people with pancreas diseases like pancreatic cancer or pancreatitis. The goal is to build a resource that helps researchers better understand these conditions and develop better screening…
Matched conditions: PANCREATIC NEUROENDOCRINE CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Fitness trackers could change how doctors assess cancer patients
Knowledge-focused Recruiting nowThis study looks at whether using a fitness tracker (like a Fitbit) can give doctors a better picture of how advanced cancer patients are functioning day-to-day. About 590 people with various cancers will wear activity monitors. The goal is to see if the activity data matches up …
Matched conditions: PANCREATIC NEUROENDOCRINE CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC